Patent · US Active

Screening methods for identifying Sp35 antagonists

US9068992B2 · kind B2 · utility

1Cited by
116References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2013
Grant dateJun 30, 2015
Priority date—
Expiry dateMar 13, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of treating diseases, disorders or injuries involving demyelination and dysmyelination, including multiple sclerosis, by the administration of an Sp35 antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.